Trial intelligence / Profile preview

Colchicine for antiviral treatment in viral diseases

2020-001806-42Phase 3Terminated

Sponsor
Società Italiana di Reumatologia
Start
Jan 2021
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of colchicine, sponsored by Società Italiana di Reumatologia. Started Jan 2021; status: terminated.

02

Drugs

colchicine

Beyond the preview

Go deeper on 2020-001806-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-001806-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call